GSK plc - 07 Nov 2022 Form 3 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
10%+ Owner
Signature
Victoria Whyte, Authorized Signatory, GSK plc
Issuer symbol
SPRO
Transactions as of
07 Nov 2022
Net transactions value
$0
Form type
3
Filing time
14 Nov 2022, 16:05:12 UTC
Previous filing
20 Sep 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SPRO Common Stock 9,190,606 07 Nov 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by GSK Equity Investments, Limited, and Glaxo Group Limited, each of which is an indirect, wholly-owned subsidiary of GSK plc (the "Reporting Person").